[1]
Srisuk, T. 2023. PREVALENCE OF SGLT2 INHIBITOR AND GLP-1 RECEPTOR AGONIST PRESCRIPTIONS IN PATIENTS WITH COMORBID DIABETES AND CARDIOVASCULAR DISEASE IN RAJAVITHI HOSPITAL. Journal of the ASEAN Federation of Endocrine Societies. 38, S3 (Nov. 2023), 56–57. DOI:https://doi.org/10.15605/jafes.038.AFES.81.